You are here : Home >Salivax™  >HIV

Salivax™ - HIV 

Catalog No.:

41251

Description:

Salivax™- HIV makes full use of the strengths of the Salivax™ platform with its unique saliva filtration and purification system to provide a high yield of antibodies. The test is designed to detect antibodies to HIV 1 and 2 by employing proprietary antigens derived with recombinant methodology from various clades of HIV 1 and certain antigens cross reacting to HIV 2, in the solid phase. The method of performing the test is an immunochromatographic assay. The antigens used in solid phase shall detect all major clades of HIV 1 including subtype 0 and HIV 2 while showing minimal cross-reactivity. A positive test will be indicated by two pink dots in the well of the test device. A negative test will have only one control dot visible. The test takes about fifteen minutes from the point of application of sample to the device.

Usage:

Salivax™-HIV is intended for screening of subjects exposed to HIV 1 or HIV 2. All subjects testing positive on Salivax™ should be confirmed by conventional ELISA, Western Blot or Radioimmunoassay.

Advantages

Like all Salivax™ products, Salivax™-HIV is non-invasive, easy to use, rapid, reliable and accurate. It requires no specialized equipment or specially trained personnel. It doesn't expose health care workers to potentially infectious body fluids. The simplicity and lack of necessity for vacuum tubes, centrifuge and refrigeration makes Salivax™-HIV very inexpensive to use especially in public health, military and home applications. The Salivax™ tests have an added ease of storage being stable at virtually all ambient temperatures.

Performance:

Salivax™-HIV will detect antibodies in saliva of patients who have been exposed to HIV 1/2. It requires 2 ml of fresh or stored saliva to yield positive results.
Please see the package insert under the heading "Salivax" on the top menu bar.